NEW YORK (GenomeWeb News) – The Genome Institute of Singapore today announced an agreement with Oxford Biodynamics to identify epigenetic signatures in stem cells.

The collaboration leverages OBD's EpiSwitch biomarker discovery platform, which allows researchers to discover and monitor highly specific epigenetic biomarkers called chromosome conformation signatures. These biomarkers define and control important elements of epigenetic and gene regulation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.